您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [美股财报]:Alto Ingredients Inc 2026年季度报告 - 发现报告

Alto Ingredients Inc 2026年季度报告

2026-08-07 美股财报 Elise
报告封面

FORM 10-Q (Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period endedJune 30, 2026 ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to _______ Commission File Number:000-21467 ALTO INGREDIENTS, INC.(Exact name of registrant as specified in its charter) (833) 710-2586(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of Exchange on Which Registered The Nasdaq Stock Market LLC(Nasdaq Capital Market) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer☐Non-accelerated filer☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of August 6, 2026, there were 77,567,564 shares of Alto Ingredients, Inc. common stock, $0.001 par value per share, and 896shares of Alto Ingredients, Inc. non-voting common stock, $0.001 par value per share, outstanding. PART IFINANCIAL INFORMATION PageITEM 1.FINANCIAL STATEMENTS.1Condensed Consolidated Balance Sheets as of June 30, 2026 (unaudited) and December 31, 20251Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2026 and 2025(unaudited)3Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 2025(unaudited)4Condensed Consolidated Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2026and 2025 (unaudited)5Notes to Condensed Consolidated Financial Statements (unaudited)6ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OFOPERATIONS.16ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.30ITEM 4.CONTROLS AND PROCEDURES.31 PART IIOTHER INFORMATIONITEM 1.LEGAL PROCEEDINGS.32ITEM 1A.RISK FACTORS.32ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.45ITEM 3.DEFAULTS UPON SENIOR SECURITIES.46ITEM 4.MINE SAFETY DISCLOSURES.46ITEM 5.OTHER INFORMATION.46ITEM 6.EXHIBITS.46SIGNATURES47 PART I - FINANCIAL INFORMATION ALTO INGREDIENTS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands) June 30,December31,20262025(unaudited)* ASSETS Amounts derived from the audited consolidated financial statements for the year ended December 31, 2025. See accompanying notes to condensed consolidated financial statements. ALTO INGREDIENTS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)(in thousands, except par value) June 30,December31,20262025(unaudited)* Accounts payable$24,219$14,509Accrued liabilities16,42416,691Current portion – long-term debt—16,600Current portion – operating leases4,9164,958Derivative instruments2771,067Other current liabilities4,5615,246Total current liabilities50,39759,071 ALTO INGREDIENTS, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(unaudited, in thousands) ALTO INGREDIENTS, INC.CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY(unaudited, in thousands) ALTO INGREDIENTS, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(UNAUDITED) 1.ORGANIZATION AND BASIS OF PRESENTATION. Organization and Business– The condensed consolidated financial statements include, for all periods presented, the accounts of AltoIngredients, Inc., a Delaware corporation (“Alto Ingredients”), and its direct and indirect wholly-owned subsidiaries (collectively, the“Company”), including Kinergy Marketing LLC, an Oregon limited liability company (“Kinergy”), Alto Nutrients, LLC, a Californialimited liability company (“Alto Nutrients”), Alto Op Co., a Delaware corporation, Alto Pekin, LLC, a Delaware limited liabilitycompany (“Alto Pekin”) and Alto ICP, LLC, a Delaware limited